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Abstract
Dissemination of metastatic cells probably occurs long
before diagnosis of the primary tumor. Metastasis
during early phases of carcinogenesis in high risk
patients is therefore a potential prevention target. The
plant polyphenol Curcumin has been proposed for
dietary prevention of cancer. We therefore examined
its effects on the human breast cancer cell line MDA-
MB-231 in vitro and in a mouse metastasis model.
Curcumin strongly induces apoptosis in MDA-MB-231
cells in correlation with reduced activation of the
survival pathway NFκB, as a consequence of
diminished ΙκΒ and p65 phosphorylation. Curcumin
also reduces the expression of major matrix
metalloproteinases (MMPs) due to reduced NFκB
activity and transcriptional downregulation of AP-1.
NFκB/p65 silencing is sufficient to downregulate c-
jun and MMP expression. Reduced NFκB/AP-1 activity
and MMP expression lead to diminished invasion
through a reconstituted basement membrane and to
a significantly lower number of lung metastases in
immunodeficient mice after intercardiac injection of
231 cells (p=0.0035). 68% of Curcumin treated but
only 17% of untreated animals showed no or very
few lung metastases, most likely as a consequence
of down-regulation of NFκB/AP-1 dependent MMP
expression and direct apoptotic effects on circulating
tumor cells but not on established metastases. Dietary
chemoprevention of metastases appears therefore
feasible.
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Introduction
Curcumin (Diferuloylmethane), a polyphenol derived
from the plant turmeric (Curcuma longa) is commonly
used as a spice component. In certain countries, Curcumin
has traditionally been applied to treat various inflammatory
disorders [1, 2]. Curcumin exerts anti-proliferative and
pro-apoptotic effects against diverse tumors in vitro [3-
5] and in vivo, as it has been found to suppress
carcinogenesis of the breast [6] and other organs [7-9].
Curcumin acts at least in part through inhibition of
the translocation of the transcription factor nuclear factor
kappaB (NFκB) [10]. In the majority of cells, NFκB exists
in an inactive form in the cytoplasm bound to the inhibitory
proteins referred to as IκB. NFκB activity is associated
with anti-proliferative effects, as well as with the induction
of apoptosis [11, 12]. As a consequence, activation of
NFκB constitutes a crucial step in tumor promotion and
progression, angiogenesis, inflammation, invasion, and
metastasis [13]. Constitutive NFκB expression correlates
with the metastatic potential of breast tumors and has
been proposed as both, a prognostic marker and a drug
target [14].
Yet, the role of NFκB in cancer progression is not
limited to its anti-apoptotic potential. NFκB also induces
expression and activation of matrix metalloproteinases
(MMPs) that enable invasive growth through the
degradation of the peritumoral matrix [15]. We and others
have shown that the expression of major MMPs correlates
with the growth behavior of tumor cells in vivo. Tumor
cell models of malignant keratinocytes [16-18] and breast
carcinoma cells [19-21] showed increasing MMP
expression levels along with increasing aggressiveness
of tumor cell growth and metastatic potential. The control
of MMP synthesis and activation can therefore be
regarded as an important target for the prevention of tumor
progression.
The promoter regions of the genes encoding MMP-
1, -2, -3, -7, -9, -12 and -13 have been analyzed. All of
them contain a proximal activating-protein-1 (AP-1)
binding site approximately 70°bp 5’ to the transcription
start [22, 23] with the exception of the gene encoding
MMP-2 whose promoter contains a modified AP-1 binding
site in a more distal position [24]. Moreover, other
transcription factors are known to influence MMP
expression as the promoter regions of these enzymes
contain NFκB-like elements as e.g in the case of MMP-
1 or MMP-13 [25-27].
Therefore natural substances like Curcumin that
down-regulate transcription of matrix degrading enzymes
are of outstanding interest for cancer prevention and treat-
ment especially as they have negligible side-effects. The
molecular mechanisms of the anti-tumor properties of
Curcumin are only partially understood, particularly in the
context of breast cancer. Hence the aim of our study
was to examine in a first step the pathways that are ac-
tivated or suppressed by Curcumin in vitro in highly in-
vasive and metastatic breast cancer cells MDA-MB-231.
The second step was to investigate the anti-metastatic
potential of the polyphenol in vivo in a model of
immunodeficient nude mice.
In the present study, we demonstrate that Curcumin
induces apoptosis and inhibits expression and activity of
the transcription factors AP-1 and NFκB leading to
diminished expression and activity of several MMPs. We
are the first to show that Curcumin significantly reduces
the number of metastases formed from intracardially
injected breast cancer cells. Down-regulation of the matrix
degrading enzymes by Curcumin through the inhibition of
NFκB/AP-1 mediated transcription can explain reduced
invasion in vitro and metastasis in vivo.
Materials and Methods
Cell Types and Culture Conditions
The human breast cancer cell line used in this study was
MDA-MB-231 (ATCC) and is referred to in the text as 231 cells.
The cell line is ER-negative and was isolated from the pleural
effusion of a patient with breast carcinoma [28, 29]. The cell
line is commonly used for breast cancer studies and is well-
defined in its growth, invasive, and metastatic characteristics.
MDA-MB-231 cells injected into the mammary fat pad of nude
mice result in the formation of tumors and distant metastases
in lungs, brain, and lymph nodes of some mice [30].
The cell line was cultured at 37°C in a humidified
atmosphere of 5% CO2. The cells were grown in MEM (Eagle’s)
with Earle’s salts supplemented with 5% heat inactivated fetal
calf serum, 1% L-glutamine solution (200mM), 1% sodium
pyruvate solution (100mM), non-essential amino acids and
vitamins. Medium was changed every 2d. For invasion assays
and zymography serum-free media were used.
Curcumin and TNFα Treatment of Cells
Curcumin with a purity of 95% was purchased from Fluka
(Buchs, Switzerland), dissolved in 0.5M NaOH as a 25mM stock
solution and stored at -20°C. For the use in cell culture a 2.5mM
solution in sterile PBS was prepared. Curcumin was applied at
an end concentration of 25µM for all assays. TNFα was
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Gene Silencing
Small interfering RNAs [r(GAU CAA UGG CUA CAC AGG
A) d(TT) and r(UCC UGU GUA GCC AUU GAU C)d(TT)]
targeted to NFκB, were synthesized and annealed (Qiagen,
Hilden, Germany). A non-silencing fluorescein labeled siRNA
(Qiagen, Hilden, Germany) was used as control for transfection
efficiency as well as for monitoring the effect of silencing NFκB
during all experiments. Cell cultures with at least 90%
transfection efficiency were used for further studies.
Transfection of MDA-MB-231 cells (40% confluency) with
siRNA was performed using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) according to the recommendations of the
manufacturer. Briefly, the transfection reagent was pre-
incubated with the siRNA Oligos either targeted to NFκB or to
an irrelevant control 30min prior to the application to the cells.
For RT-PCR, cells were harvested 6h and 24h after
transfection. For zymography, the media were replaced with
serum-free media 24h after transfection and after additional
24h, the conditioned media were used for analysis.
Preparation of Conditioned Media
Serum containing media was removed and cells were
washed 3 times with PBS, media without serum were added to
the cells and after 24h the conditioned media were harvested
and pelleted by centrifugation. The supernatants were
concentrated 50 fold by centrifugation in spin columns
(Amicon, 10kDa exclusion limit).
Protein Determination
Protein concentrations were determined by the BCA
protein assay (Pierce, Oud-Beijerland, Netherlands) with bovine
serum albumin as the standard. To cross check that equal
amounts of protein in Curcumin treated conditioned media
(yellow colored) were applied for Zymography and Western
Blot assays, SDS-PAGE was performed. Subsequent silver
staining of the proteins served as a loading control.
RNA-Extraction and Real-time PCR
Total RNA was extracted from cells according to the
method of Chomczynski and Sacchi [31] using TRI Reagent
(Sigma, Deisenhofen, Germany). Thereafter, oligo dT primed
cDNAs were synthesized using the First Strand cDNA
Synthesis Kit (Pharmacia Biotech, Freiburg, Germany) following
the manufacturer’s instructions. Quantitative RT-PCR was
performed on a Light-Cycler (Roche, Mannheim, Germany)
using the QuantiTectTM SYBR® Green PCR kit (Qiagen, Hilden,
Germany). Primers for the MMP-1, -2, -3, -9, NFκB, and c-jun
target genes as well as for the housekeeping gene RPII were
designed using the Primer3 program and purchased from
TibMolbiol (Berlin, Germany). PCR conditions were set
according to the manufacturer’s instructions provided with the
QuantiTectTM SYBR® Green PCR kit. All experiments were carried
out in duplicates as recommended for the use of the LightCycler.
The specificity of the RT-PCR products was proven by the
appropriate melting curves (specific melting temperature) and
by the expected size of the PCR products (data not shown).
Expression data were normalized on house keeping genes as
indicated in the results section.
Gel Zymography
Gelatin zymography was essentially performed as
previously described in detail [16, 17]. MMP-1, -2 and -9 controls
were purchased at Calbiochem (Merck Biosciences, Germany).
A molecular mass standard (Biorad, Germany) was used in all
experiments. These experiments were repeated three times.
Chemo-Invasion Assays
The chemo-invasion assays were performed as previously
described [32, 33]. Cells were treated for 16h in complete medium
with Curcumin and harvested with trypsin, washed with PBS,
counted, centrifuged and suspended in serum free medium.
Subsequently, equal cell numbers were placed in the upper
compartment of the Boyden chambers (1.5 x 105 cells in 800µl).
The lower compartment was filled with serum-free conditioned
media derived from NIH-3T3 cells. Curcumin was added directly
to the cells in the upper compartment. The two compartments
of the Boyden chambers were separated by a 12µm-pore size
polycarbonate filter (Corning Costar, Acton, MA) coated with
15µg/filter Matrigel (a reconstituted basement membrane [34]).
Chambers were incubated at 37 °C in 5% CO2 for 6h and 16h. At
the end of the incubation period, cells remaining at the upper
surface of the filter were removed by wiping them with a cotton
swab. Cells on the lower surface were fixed in ethanol, stained
(toluidine blue) and counted in a microscope (5 fields per filter).
Assays were performed in triplicate.
Western Blots
Western blots of conditioned media were performed as
previously described [17]. Equal amounts of protein as
determined by BCA protein assay and SDS-PAGE with
silverstaining of the Curcumin treated and non-treated cells
were subjected to SDS-PAGE and analyzed for MMP-1, -2, -3,
and -9 (kindly provided by Dr. R. Lichtinghagen, Medical
School Hannover, Germany).
Electrophoretic Mobility Shift Assay
Cells were seeded onto 150cm2 culture dishes with 25ml
culture medium and incubated until the cells reached either
subconfluent (30-50% confluency) or confluent stages. Nuclear
extracts were prepared as described previously [35].
Oligonucleotides corresponding to the consensus sequences
(AP-1 site: 5’-GAT CTG TGA CTC AGC GCG AG-3’; NFκB site:
5’-GTT AGT TGA GGG GAC TTT CCC A-GGC-3’) were labeled
with [α-32P]dATP (3000Ci/mM) and Klenow enzyme and were
incubated with 10µg of nuclear protein in 20µl of 7mM Hepes-
KOH (pH 7.9), 100mM KCl, 3.6mM MgCl2, and 10% glycerol on
ice for 20min. Poly[d(I-C)] (0.05mg/ml) was added as an
unspecific competitor. The samples were run on a 5%
nondenaturing polyacrylamide gel in a buffer containing 25mM
Tris-HCl (pH 8.0), 190mM glycine, and 1mM EDTA. Gels were
dried and analyzed by autoradiography. In order to prove the
specificity of the probes, a 50 fold excess of unlabeled probe
was incubated with the binding reaction mixture for 45 min on
ice before adding the radiolabeled DNA fragment.
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Immunocytochemistry for NFκB p65 Location
The nuclear translocation of p65 was examined by
immunocytochemistry as described previously [19, 36]. Briefly,
cells were plated on SuperFrost glass slides for adherence and
treated the next day with Curcumin. Slides were air-dried for 1h
at room temperature and fixed with ice-cold acetone. After brief
washing in PBS, slides were blocked with a blocking solution
(Biogenex, San Ramon, CA) for 1h and then incubated with a
1:100 dilution of rabbit polyclonal anti-human p65 antibody
(Santa Cruz Biotechnology, Santa Cruz, CA). After overnight
incubation, the slides were washed and then incubated with
goat anti-rabbit IgG-Alexa 594 (Invitrogen - Molecular Probes,
Carlsbad, CA) for 1h and counter-stained for nuclei with 1µg/
ml 4',6-diamidino-2-phenylindole (DAPI) for 5min. Stained slides
were mounted with mounting medium (Vector Labs, Burlingame,
CA) and analyzed under a fluorescence microscope with digital
image capture (Leica, Bensheim, Germany).
IκBα Phosphorylation
To determine the effect of Curcumin on IκBα
phosphorylation, total cellular extracts were prepared from 50-
60% subconfluent cells treated with or without 25µM Curcumin
and 10ng/ml TNFα for different times. The extracts were
analyzed by Western blot using antibodies against either IκBα
or phosphorylated IκBα (both Cell Signaling, Beverly, MA).
After transfer to a nitrocellulose membrane, the proteins were
detected by chemoluminescence (Amersham, Arlington, USA).
Flow Cytometric Analysis
The breast cell lines were grown to subconfluent and
confluent growth stages in a 24 well-plate and incubated with
25µM Curcumin for various time intervals (2, 4, 24, 28h). The
cells were harvested and then treated with (FITC)-conjugated
annexin V and propidium iodide (Annexin-V-FLUOS Staining
kit from Roche, Germany) according to the recommendations
of the manufacturer. Ten thousand events were counted for
each sample. Data were analyzed using a Flow-Cytometer
(Beckman Coulter XL-MCL, Software: System II).
MTT Assay
The antiproliferative effects of Curcumin on different
breast carcinoma cell lines were determined by the MTT (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) dye
uptake method as described earlier [37]. Briefly, the cells were
seeded in triplicate at a density of 103 or 5x102 respectively per
well in a 96-well plate in a final volume of 0.2ml complete media
and incubated for 24h at 37°C. Curcumin was added to each
well and incubation was continued for various time intervals
(0, 2, 4, 24h). The cells were washed with PBS and 50µl MTT
solution (1mg/ml in PBS) was added to each well. After 2h
incubation at 37°C, 50µl isopropanol was added. The
absorbance of MTT-formazan was measured at 570nm.
Cytotoxicity Assay
The cytotoxic effects of Curcumin in different breast
carcinoma cell lines were determinated by LDH (lactate
dehydrogenase) kinetic assay. The cells (50% confluency and
95% confluency) were seeded in triplicates in a 24-well plate in
a final volume of 1ml complete media for 24h at 37°C. Cells were
treated with 25µM Curcumin for different time intervals (0, 2, 4,
and 24h) and media were harvested and assayed. Cytotoxicity
induced by Curcumin was evaluated by measuring specific
activity of LDH secreted by the cells. LDH activity is measured
by an enzymatic assay that results in the conversion of a
tetrazolium salt into a red formazan product detected at 340nm.
Hematogenous Metastases in Immunodeficient Mice
Animal studies and research protocols were reviewed and
approved by the institutional ethics committee with and were
conducted in accordance with the national current regulations
and guidelines for the care and use of laboratory animals (D.L.
27/01/1992, n. 116). Five-week-old CD-1 Foxn1nu female mice
were obtained from Charles River Laboratories and were main-
tained under specific pathogen-free conditions and given ster-
ile food and water ad libitum. Before intracardiac tumor inocu-
lation, mice were anaesthetized with an i.p. mixture of ketamine
(50mg/kg) and xylazine (5mg/kg). Animal health and survival
rate was observed until their euthanasia due to one of the
following medical reasons: severe weights loss (exceeding 20%
of original body mass), hyperventilation, paralysis, or bone
fracture.
MDA-MB-231 cells were collected by trypsinization and
washed and resuspended in PBS. 5 x 105 cells were injected
into the heart of the mice. Mice were fed with Teklad 2019
(Harlan Winkelmann GmbH; Borchen, Germany) containing 1%
Casein (controls) or 1% Curcumin (Fluka, Buchs, Switzerland).
On day 35 after inoculation, mice were humanely sacrificed.
Following sacrifice of the animals all internal organs, including
the brain, the vertebral column, humeri, and femora were re-
moved and immersed for 24-36h in buffered formaldehyde, pH
7.4. Subsequently, all material was dissected and completely
embedded into paraffin as routinely performed. Samples con-
taining bone were first decalcified in 0.1M EDTA until com-
plete decalcification. Sections from all resulting tissue blocks
were stained for H&E. In addition, particular attention was paid
to the dissection of the lungs resulting in all samples in a cross-
section through the largest diameter of the organs. Thereby,
the pulmonary work up was standardized so that comparably
sized cross-sections through all lung samples were achieved.
Following embedding into paraffin, serial sections were pre-
pared from the lungs which were stained by immunohistochem-
istry in addition to the H&E stain.
The immunostainings comprised the localization of (hu-
man) cytokeratin (pan-keratin), p53 protein and the prolifera-
tion marker Ki-67 (all antibodies DAKO, Hamburg, Germany).
All organ sections were analyzed by light microscopy
and the presence and number of tumor cells/tumor cell aggre-
gates was recorded. In the lung samples, all tumor cells/tumor
cell aggregates present within the pulmonary parenchyma (in-
trapulmonary) were distinguished from those present at the
pleural surface and/or seen in mediastinal soft tissue
(peripulmonary). Metastases were identified by typical mor-
phology, positive reaction for (human type) cytokeratin and
enhanced proliferative capacity (Ki-67) or enhanced positivity
of tumor cell nuclei for p53 protein. All metastases were counted
irrespective of the metastasis size or the number of tumor cells
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present. The resulting metastasis frequencies were statistically
evaluated.
Results
Cell Viability and Apoptosis
We examined the effect of Curcumin on MDA-MB-
231 cell viability using two complementary tests. The MTT
assay measures cellular integrity in terms of mitochondrial
Fig. 1. Cell Viability and Apoptosis. a)
Curcumin reduces cell viability measured by
MTT assay (left panel) to approximately 50%
after 2h in MDA-MB-231 cells. Prolonged
treatment of up to 24h does not result in a
significant further reduction of viability in
these cells. LDH release into the conditioned
media of both cell lines can be observed after
24h treatment, where it reaches considerable
levels (right panel). Reduced mitochondrial
activity (left) and cytotoxicity (right) appear
to be more pronounced in subconfluent than
in confluent cells. b) Fluorescence
micrographs of annexin V and propidium
iodide stained Curcumin treated cells show
clear evidence for early apoptosis already
after 2h as evidenced by annexin V staining
(green). Most of the early apoptotic MDA-
MB-231 cells reach a late apoptotic,
propidium iodide positive stage (red) after
24h.
Table 1. Flow Cytometry Analysis of Cellular Apoptosis.
Cells treated for up to 28h with 25µM Curcumin showed clear
evidence of early apoptosis from early time points on. More
than 70% of MDA-MB-231 cells entered the suicide program
within 4h of treatment. Most of the early apoptotic cells
reached a late apoptotic, propidium iodide positive stage at
24 to 28h.
activity, while the LDH (lactate dehydrogenase) assay
indicates enzyme activities released by lysed cells into
the culture media. Figure 1a (left panel) shows that the
cells responded with a rapidly reduced mitochondrial
energy metabolism that dropped to approximately 50%
after only 2h treatment. Prolonged treatment for up to
24h did not result in a significant further reduction of
viability in these cells. The analysis of cytotoxicity,
however, showed that the early drop in mitochondrial
activity is not due to a direct toxic effect since relevant
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LDH release could be observed only after 24h treatment
(Fig. 1a, right panel). Reduced mitochondrial activity and
cytotoxicity appeared to be more pronounced in
subconfluent cells than in confluent ones.
Fig. 2. Effects of Curcumin on NFκB. a) Binding of 32P-labeled NFκB specific oligonucleotides to the cognate transcription factor
present in nuclear extracts of MDA-MB-231 cells was monitored by EMSA. Curcumin treatment of MDA-MB-231 cells for
different time intervals (left panel: lane 2: 2h; lane 3: 4h; lane 4: 6h) led to a reduced binding of NFκB to its response element as
compared to untreated cells (left panel: lane 1). The specificity of the binding was assessed for all three oligos by addition of a 50x
molar excess of cold oligonucleotides (lanes 5). Experiments were repeated at least three times. b) IκBα expression and
phosphorylation was analyzed by Western blots using total cellular extracts and specific antibodies against phosphorylated IκB
(pIκB). Untreated control cells contain low amounts of phospho-IκB. IκB phosphorylation is strongly induced by treating the
cells with the NFκB activator TNF-? for one hour. When Curcumin is added to the cells in the absence of TNF-α for only 30min,
a slight reduction in phospho-IκB as compared to basal levels is observed. In Curcumin treated cells that are also stimulated with
TNF-α, the TNF-α dependent induction of phospho-IκB is strongly reverted. Phosphorylation of the p65 subunit of NFκB is
induced by TNF-α, which can be reduced by Curcumin (bottom panel). Protein amounts loaded onto the gels are controlled by
concomitant staining with antibodies against tubulin. c) Immunofluorescent NFκB translocation assays using specific antibodies
against the p65 unit (left panels) show that NFκB in untreated control cells is located almost exclusively in the nucleus of the cells
(DAPI stain, right panels). Upon treatment of the cells with Curcumin, fluorescence increases in the cytoplasm and the nuclear
signal decreases indicating that more NFκB is retained in the cytoplasm as shown here after 4h of treatment with the polyphenol.
To clarify whether the LDH release correlated with
induction of apoptosis, we treated the cells for up to 28h
with 25µM Curcumin. From early time points on (2 and
4h, Table 1) the cells showed clear evidence of early
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Fig. 3. Crosstalk between NFκB and AP-1. a) Reduced binding
of nuclear proteins from Curcumin treated cells to the AP-1
consensus sequence (see Material and Methods) could be
shown by mobility shift experiments which were performed for
treated (lanes 2: 2h; lanes 3: 4h; lanes 4: 6h) and untreated
(lanes 1) MDA-MB-231 cells using 10µg of nuclear protein
incubated with the 32P-labeled oligonucleotide. Cells of both
lines treated with Curcumin show a clear reduction in the specific
bands for the transcription factor AP-1 in comparison to
untreated cells (lanes 1). The specificity of the binding was
assessed for all three oligos by addition of a 50x molar excess
of cold oligonucleotides (lanes 5). Experiments were repeated
at least three times. b) mRNA expression of the AP-1 subunit c-
jun was reduced in MDA-MB-231 cells upon treatment from 1h
to 20h with the polyphenol as evidenced by Real Time RT-PCR.
A statistically significant 50% depletion of c-jun expression
was reached after 2h of Curcumin treatment. Experiments were
performed in triplicates. c) NFκB silencing of the p65 subunit
resulted in a more than twofold depletion of p65 mRNAs 6 and
24h after transfection with p65 siRNAs. The effects on mRNA
expression were similar for c-jun which was reduced in p65
silenced MDA-MB-231 cells (left panel). *= p<0.05 (unpaired
t-test). Experiments were repeated at least three times.
apoptosis in terms of translocation of phospholipid
phosphatidylserine from the inner to the outer leaflet of
the plasma membrane, where it becomes accessible to
annexin V staining as confirmed by flow cytometry
analysis. More than 70% of cells entered the suicide
program within 4h treatment. Most of the early apoptotic
cells reached a late apoptotic, propidium iodide positive
stage after 24 to 28h. Figure 1b shows fluorescence
micrographs of annexin V and prodium iodide staining in
Curcumin treated cells. Induction of apoptosis in 231 cells
was consistent with the observed effect on cell viability.
The raise in LDH release, which we observed in these
cells, appeared simultaneously with propidium iodide
stained late apoptotic cells. The release of LDH may
therefore be attributed to apoptotic disruption of the cell
membrane.
Effects of Curcumin on IκB Phosphorylation and
NFκB Activation
Nuclear extracts from Curcumin treated and
untreated cells were applied to electrophoretic mobility
shift assays (EMSA) where the binding of transcription
factors is revealed by the retarded electrophoretic
migration of radioactively labeled oligonucleotides of the
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specific binding sequence (Fig. 2a). The specificity of
the binding was assessed by addition of a 50fold excess
of cold oligonucleotides that abolished the band shifts
observed (Fig. 2a; lane 5). Addition of an unrelated mutant
oligonucleotide had no effect on NFκB binding (data not
shown). Curcumin treatment for 2, 4, and 6h of MDA-
MB-231 cells (Fig. 2a, lanes 2, 3, and 4, respectively)
show a clear reduction in the specific bands for the
transcription factor NFκB in comparison to untreated cells
(lane 1).
As a prerequisite to p65 activity inside the nucleus,
we have followed IκB phosphorylation by Western Blots
of total cellular extracts using specific antibodies that
recognize IκBα only in its phosphorylated form (Fig. 2b).
In untreated control cells, only few phospho-IκBα is
present. IκBα phosphorylation is strongly induced by
treating the cells with the NFκB activator TNF-α for one
hour. When Curcumin was added to the cells, in the
absence of TNF-α, for only 30 min, the phospho-IκBα
band was reduced as compared to basal levels. In
Curcumin treated cells that were also stimulated with
TNF-α, the TNF-α dependent induction of phospho-IκBα
was strongly reverted (Fig. 2b). Phosphorylation of the
p65 subunit of NFκB followed a similar pattern: the
induction by TNF-α was inhibited by the polyphenol (Fig.
2b, bottom panel).
Reduced NFκB activitation led to a diminished NFκB
translocation to the nucleus as monitored by
immunofluorescence analyses using specific antibodies
against the p65 unit of NFκB (Fig. 2c). In untreated
MDA-MB-231 control cells, NFκB was mainly located
in the nucleus with a minor fluorescent signal detectable
in the cytoplasm of the cells (Fig. 2c, upper panel). Upon
4h treatment of the 231 cells with Curcumin, fluorescence
in the cytoplasm increased and the nuclear signal
decreased indicating that NFκB was retained in the
cytoplasm (Fig. 2c, lower panel). The results of the
EMSA, the translocation assays and Western blots
concordantly show an effect of Curcumin on NFκB
activation in these breast cancer cells.
Effects of Curcumin on AP-1 and NFκB/AP-1
Cross-Talk
EMSAs of nuclear extracts of the cells (Fig. 3a)
showed a clear reduction of AP-1 binding upon treatment
with Curcumin for 2, 4 and 6h (lanes 2, 3, and 4
respectively) when compared to untreated cells (lane 1).
The specificity of the binding was assessed by addition
of a 50fold excess of cold oligonucleotides that abolished
the band shifts observed (Fig. 3a; lane 5). Addition of an
unrelated mutant oligonucleotide had no effect on AP-1
binding (data not shown).
Reduced AP-1 binding to its cognate response
element can be attributed to reduced expression of the
AP-1 factor, c-jun, as evidenced by Real Time RT-PCR
analyses of MDA-MB-231 cells (Fig. 3b). After only 1h
of Curcumin treatment, c-jun expression was reduced
with further decrease up to 20h. This effect is statistically
significant.
We wished to test the hypothesis that reduced AP-
1 activity is due to an effect of NFκB on c-jun mRNA
abundance and therefore, we performed silencing
experiments using small interfering oligonucleotides
specific for NFκB/p65 that we transfected into MDA-
MB-231 cells. The effects on transcription of p65 itself
and on c-jun were analyzed by Real Time RT-PCR (Fig.
3c). A more than twofold depletion of p65 mRNAs at 6
and 24h after transfection with anti-p65 siRNAs that was
paralleled by a three- to fourfold reduction of c-jun mRNA
expression at 6 and 24h, respectively, was observed in
231 cells. We are therefore confident that the effect of
Curcumin observed depends, at least partially, on reduced
NFκB activity.
Matrix Metalloproteinase Expression
We measured MMP mRNA expression by
quantitative Real Time RT-PCR (Fig. 4a) and normalized
expression values on those obtained for the housekeeping
gene RNA-polymerase II. The normalization also
monitors the general transcriptional activity of the cells in
a way to exclude any influence of late apoptotic cells on
the results. Previous analyses showed that the major
MMPs expressed by 231 cells were MMP-1, -2, -3 and -
9, although the latter is present only in very small amounts
[19]. MMP-2 protein is expressed at considerable levels
(see below) yet only low levels of the appropriate
transcripts were detectable, probably due to unstable
mRNAs. Curcumin treatment of 231 cells resulted in
strongly diminished levels of MMP-1 and MMP-2 mRNA
already after 2h leading to 3.45 fold (MMP-1) and 2.5
fold (MMP-2) reduction of expression after 20h. MMP-
3 and -9, on the other hand, showed no considerable
alteration of expression (Fig. 4a).
Well in line with the results obtained from Real Time
RT-PCR, Western blot analyses of cell supernatants (Fig.
4b) revealed a strong down-regulation of MMP proteins
upon treatment with the polyphenol. Accumulation of
newly released MMPs secreted into fresh serum-free
medium added at the beginning of the time course, was
monitored in the presence (+) or in the absence (-) of
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Fig. 4. Effect of Curcumin
on MMP Expression. a)
Quantitation of mRNA by
real time RT-PCR of breast
cancer cells treated with
25µM Curcumin for 2 and
20h revealed a significant
downregulation of MMP-1
and -2 in MDA-MB-231
already after 2h with
ongoing effects up to 20h
treatment. Experiments were
performed in triplicate; error
bars indicate SD; *=p<0.05
(one way Anova with
Bonferroni’s post test). b)
Western blot analysis of
supernatants of cells
treated for several time
intervals with Curcumin
revealed reduced amounts
of MMP-1 and MMP-2. c)
Zymography of gelatino-
lytic (e.g. MMP-2 and -9)
and caseinolytic enzymes
(e.g. MMP-1) showed a
reduction of proteolytic
activities present in
conditioned media from the
cells treated for different
time intervals with Curcu-
min as compared to those
of untreated cells. MMPs
were identified according to
their migration behavior as
compared to a molecular
mass standard (not shown)
and to MMP-1, -2 and -9
controls (lanes indicated
with S and the according
MMP control). The faint
gelatinolytic band visible in
supernatants of MDA-MB-
231 cells below the bands
identified as MMP-2 most
probably corresponds to
MMP-1 activity which is detectable also in gelatin zymographies. The caseinolytic band at about 89 kDa (molecular mass
standard not shown) which could be detected above the lytic bands of MMP-1 was not yet identified (marked in Figure 4c by an
asterisk). d) P65 expression is reduced to 40% and 25% after 6 and 16h of silencing, respectively, by means of transfection of
siRNAs specific for p65. Silencing of the NFκB subunit led to a significantly reduced expression of mRNAs (real time PCR, left
panel; *=p<0.05, unpaired t-test) and proteins (Western blot, right panel) of MMPs 1, and 2 in MDA-MB-231 cells.
25µM Curcumin. We found that MMP-1 and -2 protein
were released into the supernatants of 231 cell cultures.
The amount of MMP-1 protein secreted into the media
of non-treated cells was almost completely abrogated
already after 3h incubation in the presence of Curcumin.
The effect on MMP-2 was similar and reached a plateau
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after 15h. Even after 24h, MMP-1 and -2 proteins were
not detectable in supernatants of Curcumin treated cells.
The Western blot analyses thus show that MMP
expression was also regulated post transcriptionally:
MMP-1 and -2 levels appeared to be more drastically
regulated at the protein level (Fig. 4b) than at the mRNA
level (Fig. 4a).
The Western blot data were further confirmed by
zymography analyses on substrate containing gels
visualizing the enzymatic activities present in cell culture
supernatants. The electrophoretically separated proteases
were detected as translucent bands on the Coomassie
brillant blue stained substrate background (gelatin for
MMP-2 and -9, casein for MMP-1). The accumulation
of MMP activity released into fresh medium was
monitored in comparison to purified control MMPs (figure
4c, lanes labeled “S”). 231 cells responded to the Curcumin
treatment with a transient reduction in MMP-2 and -9
activities, comigrating with the respective controls,
detected on gelatin gels (Fig. 4c, upper panel). A persistent
suppression of MMP-1 activity, comigrating with a MMP-
1 control, was observed on casein containing gels (Fig.
4c, lower panel).
The faint gelatinolytic band visible at 51kDa
(molecular mass standard not shown; below the MMP-2
bands; Fig. 4c, upper panel) most probably corresponds
to MMP-1 activity which is detectable, though weaker,
also in gelatin zymographies. The caseinolytic band at
about 89kDa (molecular mass standard not shown) which
could be detected above the lytic bands of MMP-1 was
not yet identified (marked in Fig. 4c, lower panel by an
asterisk).
We then asked whether the reduced NFκB activation
operated by Curcumin and the effect of the polyphenol
on MMP expression are causally linked or just coincident.
For this purpose we silenced the expression of the NFκB
subunit, p65, by means of transfecting the cells with p65
siRNAs. The siRNAs reduced p65 expression to 40%
and 25% as compared to cells transfected with non-
specific siRNAs after 6 and 16h, respectively. In the
silenced cells, expression of MMP-1 and -2mRNA (Fig.
4d; left panel) and protein (Fig. 4d; right panel) was
significantly reduced. The effect of Curcumin on NFκB
thus explains the diminished MMP expression.
Invasion
Breast cancer cells revealed a diminished expression
of major MMPs upon Curcumin treatment and we
therefore investigated the influence of the polyphenol on
the invasive capacity through a reconstituted basement
membrane. If the filter is covered with a reconstituted
basement membrane (Matrigel) active invasion and
proteolytic digestion of the matrix is required for the cells
to respond to the stimulus (Fig. 5). Invasion was
significantly reduced by Curcumin after only 6h of
treatment with the polyphenol. This establishes a
functional consequence of decreased MMP production.
Mouse Metastasis of Breast Cancer Xenografts
2 x 105 subconfluent 231 cells were injected into the
heart of nude mice that were subsequently divided into
two groups that received casein or casein-Curcumin diets.
This route of administration, though leading to suboptimal
absorption of the polyphenol that is mainly excreted with
the faeces, was chosen in consideration of the probable
route of administration for dietary chemopreventive
agents. Mice were observed for 5 weeks within which
the two groups did not show any differences, especially,
Curcumin treated mice did not reveal any side effects of
the treatment, and the weights of the animals of the two
groups were comparable.
After five weeks, mice were sacrificed and all
internal organs including the brain, the vertebral column,
and both humeri and femora were collected and examined.
Brain, Humeri, femura and vertebral column were free
Fig. 5. Invasion. Treatment of MDA-MB-231 cells with 25µM
Curcumin for 6h led to a significant decrease of the invasive
capacity as compared to untreated cells. The reduced number
of invading cells after only 6h indicates that reduced invasion
cannot be attributed to cell death. Fibroblast conditioned
medium was used as chemoattractant and Matrigel as an
extracellular matrix equivalent. Experiments were performed in
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Fig. 6. Hematogenous Lung Metastases. 5 x 105 MDA-MB-231 cells were injected into the heart of immunodeficient mice.
Animals were untreated (control) or treated with Curcumin in the diet and sacrificed after 5 weeks. Lungs were removed fixed and
four sections for each animal were analyzed for metastases. a) histology of metastases formed The immunolocalization of
(human) cytokeratin in the periphery of a mouse lung specimen reveals multiple selectively and positively stained tumor cells and
small tumor cell aggregates (brown color). Immunohistochemical staining for p53 protein of a mouse lung specimen also shows
multiple positively labeled cell nuclei (brown color) suggesting implanted breast cancer metastases. Localization of the cell
proliferation antigen Ki-67 with positive labeling of isolated tumor cell groups (brown color) indicates cell proliferation of the
transplanted tumor cells. The overview of lung tissue 5 weeks after intracardiac tumor cell injection shows small groups of cells
with typical morphological features of tumor cells (polymorphism, atypia, mitotic activity). (A-D original magnification x 400; A:
anti-human cytokeratin; B: anti-human p53 Protein; C: anti-human Ki-67 antigen (MIB-1); D: H&E) b) Number of metastases
formed The scattergrams report the numbers of metastases found in each of the untreated (control, n=18) and Curcumin treated
(Curcumin; n=19) animals (mean of 4 sections analyzed). Mean number of metastases per animal are reduced in Curcumin treated
animals. Note the high number of animals with very few metastases in treated animals (Mann-Whitney p=0.0035).
of metastases. Lung metastases were counted after
preparation of eosin-hematoxilin stained paraffin sections.
In both study groups, tumor cells/ cell aggregates were
seen in the intrapulmonary and the peripulmonary
compartment, though to different numbers.
Peripulmonary metastases are more likely to be derived
from direct dissemination during the intercardiac injection.
We therefore limited our analysis to intrapulmonary
metastases that are of hematogenous origin. The tumor
cell morphology showed characteristic atypia, significant
expression of human p53 protein was observed only in
tumor cells. Vitality of the tumor cells was confirmed by
Table 2.  Curcumin Inhibits Lung Metastases.
Curcumin treated animals had less lung metastases.
Four controls and three treated animals had high total
metastases counts (>10) and the number of animals
with very few metastases (<3) was higher in treated
(13 of 19 animals; 68%) than in untreated animals (3 of
18 animals; 17%). Four Curcumin treated and none of
the control animals remained metastases free.
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a high number of proliferating Ki-67 positive cells thus
excluding tumor cell dormancy (Fig. 6a). Tumors of
treated and untreated animals were similar in dimension,
morphology and histology.
Figure 6b demonstrates that Curcumin prevented
lung metastases in a highly significant manner (Mann-
Whitney test, p=0.0035). The effect of Curcumin on lung
metastasis becomes also evident from Table 2 that shows
the mice subdivided in ranks with no, very few (<3),
several (3-10) and many (>10) metastases. The number
of animals with very few metastases (<3) was
dramatically increased in treated (13 of 19 animals; 68%)
as compared to untreated animals (3 of 18 animals; 17%).
Four Curcumin treated and none of the control animals
remained metastases free. 4 controls and 3 treated
animals had high total metastases counts (>10).
Metastases of other tissues were rare in both groups.
Discussion
Chemopreventive agents such as Curcumin are
natural or synthetic substances that suppress or slow down
tumor formation [38]. Most of them are plant extracts
and have negligible side effects. Chemoprevention has
two targets: (i) avoidance of neoplastic cell transformation
and (ii) inhibition or retardation of tumor promotion and
progression.Tumor metastasis is the major determinant
of mortality of cancer patients. Yet most of the cells
dispersed from the primary tumor never form colonies
because they fail to reach the target tissue or do not grow
once they have reached it. All steps in metastasis, from
invasion of the tumor surrounding stroma and distribution
through the blood flow to extravasation from capillaries
and growth in the target tissue, rely on host factors [39-
41]. In an ideal setting, chemoprevention would therefore
target both the actual tumor cells and the host.
NFκB comes close to an ideal target inasmuch as it
acts in the tumor cell itself, where it controls survival
pathways [42] as well as in the host, where it regulates
the expression of genes involved in inflammatory
processes and stress responsiveness [42-44] that may
promote tumor progression and metastasis through the
induction of angiogenesis and through the expression of
tethering molecules on the surface of activated
endothelium [45]. NFκB has been shown to be
constitutively activated in breast cancer cells [38], where
it mediates a wide variety of cellular processes involving
growth, differentiation, and apoptosis. Increasing evidence
of deregulation of pathways that converge on NFκB in
various human breast cancer cell lines and primary tumors
supports a role for NFκB in mammary carcinoma
progression [38, 46]. As a consequence, inhibition of NFκB
could prevent tumor progression and some
chemopreventive polyphenols act at least in part through
the inhibition of NFκB [47, 48].
Here, we establish an anti-metatastic role of the
strong NFκB inhibitor Curcumin and outline the molecular
pathways that lead to a reduced metastatic potential of
mammary carcinoma cells in an animal model of
hematogenous metastasis. We have analyzed the effects
of the polyphenol on the highly invasive and metastatic
breast cancer cell line MDA-MB-231. We chose to use
a concentration of 25µM Curcumin since dose dependent
effects in the range of 1-50µM had been reported for
breast cancer cell lines with strongest effects between
20 and 50µM [49].
Several studies have shown anti-metastatic proper-
ties of Curcumin in vivo [50-54]. However, it is important
to distinguish between effects on the formation versus
growth of metastases. Most studies analyzed metastases
formed from a primary tumor of subcutaneously injected
cells. Effects on primary tumor growth are most likely to
also affect the number of metastases formed and no dis-
tinction between the two processes is therefore possible
[50]. The molecular effects of Curcumin on the NFκB
pathway are well established [55-57] yet the correlation
between these effects and breast cancer invasion and
metastasis is not clear. The in vitro results presented
here clearly proof that Curcumin treatment reduces the
viability and induces apoptosis in breast cancer cells as a
consequence of disruption of the NFκB activation path-
way. The intrusion probably occurs at a step before IκB
phosphorylation as we could demonstrate that Curcumin
treatment of MDA-MB-231 cells inhibits IκBa phospho-
rylation which in turn reduces nuclear translocation and
activation of p65/NFκB. Aggarwal and coworkers have
recently reported similar observations on U937 (human
myeloid leukemia) and A293 (human embryonic kidney)
cells [57].
Furthermore, our in vitro data confirm that the role
of NFκB in tumor progression is not restricted to its
influence on cell death but comprises the transcriptional
regulation of gene products related to invasion and
metastasis such as the matrix degrading enzymes MMPs
which exhibit functional NFκB binding sites in their
promoter regions [58, 59].
In addition to NFκB, another transcription factor -
AP-1 - is also known to be affected by Curcumin [60].
This is likely to be due to the inhibition of NFκB activation
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since gene silencing of p65 in MDA-MB-231 cells also
reduced the messenger RNA levels of the AP-1 subunit
c-jun. Park et al. [61] recently showed that curcuminoids
suppress the formation of DNA-Jun-Fos complexes. This
is due at least in part to reduced c-jun transcription similar
to what we observe here, yet Park et al. observed this
effect at much higher, millimolar concentrations. A direct
cross-talk between NFκB and AP-1 becomes even more
likely given the presence of a perfect NFκB binding
element 994 nucleotides upstream of the transcription start
site in the c-jun promoter.
Both transcription factors - NFκB and AP-1 - are
known to regulate MMP expression [23, 25, 59, 62] and
enhanced production of MMPs is associated with a more
aggressive tumor growth, a higher metastatic potential,
and poor clinical outcome of malignant tumors [63-66].
The effect on NFκB and AP-1 mediated expression
of MMPs probably explains the significantly decreased
metastatic potential of breast cancer cells that we
observed in vivo. The number of hematogenous
metastases obtained through intracardial injection of
MDA-MB-231 cells was significantly lower in Curcumin
treated animals but size and morphology of the metastases
formed are indistinguishable from those seen in control
animals. Decreased formation of metastases in Curcumin
treated animals could be due to effects of the polyphenol
on the tumor environment, inflammation or angiogenesis.
The histological examination of the metastases from
treated and untreated animals does, however, not reveal
any such difference. We therefore suggest that a concerted
action of MMP inhibition and reduction of survival of single
cells, probably due to the repression of an anti-anoikis
effect of NFκB, may explain why Curcumin has an effect
on the formation of metastases rather than on their growth
once they are established. Formation of metastases from
prostate carcinoma xenografts has also been reported to
be affected by Curcumin [50]. The authors correlated
reduced metastases to the direct action of Curcumin on
MMP-9 activity. However, MMP-9 is expressed at very
low levels in the breast cancer cells used in our study and
metastasis formation crucially relies on collagen I
degradation operated by MMP-1 expressed by MDA-
MB-231 cells and not by the gelatinase MMP-9 that
cannot degrade the ECM compound native collagen and
therefore promotes only local tumor growth. Mammary
carcinoma cells show highest levels of MMP expression
in sparse cultures or at the tumor periphery, where cells
grow in a less compact pattern and three-dimensional
cultures of these cells have an elevated proteolytic activity
in regions of low cellular density [67-69]. Well in line with
our previous observations, we show that the effects of
Curcumin on cell growth and viability are more
pronounced in subconfluent cells and could thus have a
particular impact on single metastasizing cells.
It is difficult to establish whether the effects on the
NFκB pathway observed in vitro persist in vivo, or if
they are limited to single cells present in the blood flow.
The few metastases formed in Curcumin treated animals
probably have managed to escape the drug effects and
are therefore not expected to show any alteration in NFκB
dependent cell survival or MMP regulation.
Aggarwal et al. very recently established that
Curcumin can overcome chemoresistance in breast can-
cer cells through the inhibition of taxol induced activation
of NFκB [70]. These data are consistent with ours and
we extend this concept to constitutive, therapy independ-
ent activation of NFκB, and thus establish that Curcumin
is also suited for the prevention of metastasis.
The present work makes one step in this direction
since we establish for the first time Curcumin effects on
the formation of metastases through the inhibition of
NFκB/AP-1 mediated expression of MMPs. Prevention
of breast cancer in subjects at elevated risk using
Curcumin is therefore conceivable. Our data indicate,
however, that beneficial effects of primary prevention
with Curcumin will be limited to patients whose tumors
have an intact IKK/IκB signaling, an information that is
not available unless the tumor has formed and can be
analyzed. In similar way, the functionality of IKK/IκK of
the primary tumor should be monitored if Curcumin is to
be added to chemotherapy as proposed by Aggarwal et
al. [70].
Curcumin is consumed at considerable quantities in
regions where it belongs to the normal diet [71]. It appears,
however, unlikely that the substance could become a
supplement for primary cancer prevention in its original
form, in particular because of its poor bioavailability. We
are convinced that the effects on the formation of
metastases in vivo described here could be obtained by
much lower doses of a more water soluble analog. NFκB
inhibitors like Curcumin may therefore be considered lead
compounds for the development for properly targeted
chemopreventive agents.
Abbreviations
AP-1 (activating protein 1); CPB (cyclophilin B);
G-6-PDH (glucose-6-phosphate dehydrogenase);
GAPDH (glyceraldehydes-3-phosphate dehydrogenase);
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